BiomX (NYSEAMERICAN:PHGE) Stock Price Down 1.3% – What’s Next?

BiomX Inc. (NYSEAMERICAN:PHGE) shares fell 1.3% on Wednesday . The company traded as low as $0.74 and last traded at $0.77. 40,241 shares traded hands during trading, a decline of 26% from the average session volume of 54,108 shares. The stock had previously closed at $0.78.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a “buy” rating and issued a $2.00 price target on shares of BiomX in a report on Wednesday, January 8th.

BiomX Trading Down 1.3 %

The firm has a market capitalization of $14.00 million, a P/E ratio of -0.24 and a beta of 1.26.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).